The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.

This invention relates to a topical herbal formulation that is particularly suitable for the treatment of wounds and a process for the manufacture thereof. More specifically, this invention relates to a topical wound-healing herbal formulation comprising gotu kola (Centella asiatica), greater plantain (Plantago major), figwort (Scrophularia nodosa), yarrow (Achillea millefolium) and Pau d'Arco (Tabebuia impetiginosa). The herbal formulation has both anti-inflammatory and anti-microbial properties. The formulation is particularly effective in the treatment of horse wounds, preventing the formation or raised hairless scars and promoting hair regrowth in the horse without the need for the introduction of an extracellular matrix. The formulation is also suitable for the treatment of general skin disorders in humans including, but not limited to, eczema and nappy rash.

This invention relates to a topical herbal formulation that is particularly suitable for the treatment of wounds and a process for the manufacture thereof. More specifically, this invention relates to a topical wound-healing herbal formulation comprising gotu kola (Centella asiatica), greater plantain (Plantago major), figwort (Scrophularia nodosa), yarrow (Achillea millefolium) and Pau d'Arco (Tabebuia impetiginosa). The herbal formulation has both anti-inflammatory and anti-microbial properties. The formulation is particularly effective in the treatment of horse wounds, preventing the formation or raised hairless scars and promoting hair regrowth in the horse without the need for the introduction of an extracellular matrix. The formulation is also suitable for the treatment of general skin disorders in humans including, but not limited to, eczema and nappy rash.

This invention relates to a topical herbal formulation that is particularly suitable for the treatment of wounds and a process for the manufacture thereof. More specifically, this invention relates to a topical wound-healing herbal formulation comprising gotu kola (Centella asiatica), greater plantain (Plantago major), figwort (Scrophularia nodosa), yarrow (Achillea millefolium) and Pau d'Arco (Tabebuia impetiginosa). The herbal formulation has both anti-inflammatory and anti-microbial properties. The formulation is particularly effective in the treatment of horse wounds, preventing the formation or raised hairless scars and promoting hair regrowth in the horse without the need for the introduction of an extracellular matrix. The formulation is also suitable for the treatment of general skin disorders in humans including, but not limited to, eczema and nappy rash.

The present invention relates to the preparation technical field of traditional Chinese medicine and more particularly, to a traditional Chinese medicine eye drops and the preparation method thereof. The traditional Chinese medicine components of the traditional Chinese medicine eye drops provided by the embodiments of the invention comprise: ginseng radix et rhizoma of 5-10 wt %, scrophulariae radix of 15-20 wt %, xanthii fructus of 5-10 wt %, bovis calculus sativus of 5-10 wt %, carthami flos of 5-10 wt %, borneolum of 5-10 wt %, senecionis scandentis herba of 25-35 wt %, fibraureae caulis of 5-15 wt % and motherwort fruit of 5-10 wt %.

The present invention relates to the preparation technical field of traditional Chinese medicine and more particularly, to a traditional Chinese medicine eye drops and the preparation method thereof. The traditional Chinese medicine components of the traditional Chinese medicine eye drops provided by the embodiments of the invention comprise: ginseng radix et rhizoma of 5-10 wt %, scrophulariae radix of 15-20 wt %, xanthii fructus of 5-10 wt %, bovis calculus sativus of 5-10 wt %, carthami flos of 5-10 wt %, borneolum of 5-10 wt %, senecionis scandentis herba of 25-35 wt %, fibraureae caulis of 5-15 wt % and motherwort fruit of 5-10 wt %.

The present invention relates generally to a methods of treating ear infections and clearing excess fluid from Eustachian tubes.

The present invention relates generally to a methods of treating ear infections and clearing excess fluid from Eustachian tubes.

The present invention relates generally to a methods and apparatuses for treating ear pain and clearing excess fluid from Eustachian tubes.

The present invention relates generally to a methods and apparatuses for treating ear pain and clearing excess fluid from Eustachian tubes.